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Newcastle disease virus (NDV) fusion (F) protein directs membrane fusion, which is required for virus
entry and cell-cell fusion. We have previously shown that free thiols are present in cell surface-expressed
NDV F protein and that blocking the production of free thiols by thiol-disulfide exchange inhibitors
inhibited the membrane fusion mediated by F protein (J Virol. 81:2328–2339, 2007). Extending these
observations, we evaluated the role of the overexpression of two disulfide bond isomerases, protein
disulfide isomerase (PDI) and ERdj5, in cell-cell fusion mediated by NDV glycoproteins. The overexpres-
sion of these isomerases resulted in significantly increased membrane fusion, as measured by syncytium
formation and content mixing. The overexpression of these isomerases enhanced the production of free
thiols in F protein when expressed without hemagglutination-neuraminidase (HN) protein but decreased
free thiols in F protein expressed with HN protein. By evaluating the binding of conformation-sensitive
antibodies, we found that the overexpression of these isomerases favored a postfusion conformation of
surface-expressed F protein in the presence of HN protein. These results suggest that isomerases belong-
ing to the PDI family catalyze the production of free thiols in F protein, and free thiols in F protein
facilitate membrane fusion mediated by F protein.
Newcastle disease virus (NDV), like other paramyxoviruses,
enters host cells by the fusion of the viral membrane with host
cell plasma membranes. This fusion is triggered by the attach-
ment of the hemagglutination-neuraminidase (HN) protein to
the sialic acid-containing host cell receptors and is mediated by
the fusion (F) protein. Based on similarities in protein struc-
ture and fusion mechanisms, paramyxovirus fusion proteins,
influenza hemagglutinin proteins, and retroviral envelope
(Env) proteins have been categorized as class I fusion proteins
(reviewed in references 3, 30, and 35).
Class I fusion proteins are synthesized as single polypeptides
(F0 in paramyxoviruses) that form homotrimers and are
cleaved into two subunits, a membrane-distal (F2 in paramyxo-
viruses) and a membrane-anchored subunit (F1 in paramyxo-
viruses). At the amino terminus of the membrane-anchored
subunit is a fusion peptide, which inserts into the target mem-
branes upon fusion activation. Adjacent to the fusion peptide
is a conserved heptad repeat, HR1, and another conserved
heptad repeat, HR2, is located next to the transmembrane
domain (reviewed in references 3 and 20). The F protein, in a
metastable, cleaved form on the virus or cell surface, can be
triggered to undergo conformational changes, which result in
membrane fusion. These conformational changes are triggered
by the binding of HN protein to receptors (14, 18, 28). The
conformational changes proposed to take place in F protein
during the activation and the onset of fusion (37) are signifi-
cant, but how this refolding is accomplished is unclear.
A potential mechanism to facilitate these conformational
changes is suggested by a number of studies of different vi-
ruses, which have shown that, during membrane fusion, fusion
glycoproteins undergo thiol/disulfide isomerization, leading to
the reduction of disulfide bonds and the production of free
thiols in fusion glycoproteins (1, 7, 15, 16, 25, 27, 33). The
production of free thiols in these glycoproteins is essential for
membrane fusion and may facilitate conformational changes
required for fusion. In some viruses, like murine leukemia
virus (MLV), the thiol/disulfide isomerization is thought to be
mediated by an isomerase motif, Cys-X-X-Cys (CXXC), in the
viral Env glycoprotein sequence, and this isomerization is trig-
gered by the binding of glycoprotein to its receptor (25, 33, 34).
For viruses that do not have a CXXC motif within the glyco-
protein sequence, like human immunodeficiency virus type 1
(HIV-1), the thiol/disulfide isomerization is thought to be cat-
alyzed by host cell proteins, protein disulfide isomerase (PDI)
or related proteins, that have a CXXC motif. This conclusion
is based on studies showing the inhibition of HIV-1 entry and
cell-cell fusion by inhibitors of the PDI family of isomerases (4,
7, 9, 16, 27).
In another study, the contribution of PDI in HIV-1 Env-
mediated membrane fusion was evaluated by decreasing the
expression of endogenous PDI protein using short interfering
RNA (24). It was shown that the downregulation of PDI did
not significantly inhibit the membrane fusion mediated by
HIV-1 Env. The authors suggested that other isomerases of
the PDI family also are involved in disulfide bond reduction
and that this function is redundant, as many of the members of
the host cell PDI family of proteins have similar catalytic do-
mains and can catalyze the reduction of disulfide bonds (re-
viewed in reference 2).
PDI is a member of a family of 19 structurally related
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isomerases with a thioredoxin-like domain (reviewed in refer-
ence 2). Most of the isomerases in the PDI family have a
CXXC motif that catalyzes the formation, reduction, and re-
arrangement of disulfide bonds in proteins (2, 5, 23, 36). These
isomerases are involved primarily in the folding of proteins in
the endoplasmic reticulum (ER), catalyzing the formation of
disulfide bonds. Indeed, most of these proteins have ER re-
tention signals (2). However, in recent years, isomerases from
the PDI family have been shown to be present on cell surfaces,
both in functional assays and biochemical assays (8). The
mechanisms involved in the expression and retention of these
proteins at cell surfaces are unknown, but it has been specu-
lated that they are bound to resident host cell surface proteins
(2, 8, 10, 32). Cell surface disulfide isomerases are proposed to
be involved in processes such as cell adhesion, nitric oxide
signaling, and the reduction of disulfide bonds in the cell entry
proteins of viruses (reviewed in references 8 and 13, 32).
We recently reported that free thiols also may be detected in
cell surface-expressed NDV fusion protein, and that these free
thiols are required for cell-cell membrane fusion (12). We
showed that cell-cell membrane fusion as well as viral entry was
inhibited by DTNB [55-dithio-bis(2-nitrobenzoic acid)], a
nonspecific inhibitor of free thiols, bacitracin, an inhibitor of
PDI family of isomerases, and anti-PDI antibodies. However,
anti-PDI antibodies inhibited membrane fusion less efficiently
than the two inhibitors. This result suggested that the reduc-
tion of disulfide bonds in the F proteins is accomplished by
other members of the PDI family.
To explore the role of PDI and other PDI-like isomerases on
F protein function, we studied the effects of the overexpression
of two different thiol isomerases, PDI and ERdj5, on F pro-
tein-mediated fusion and on the conformation of surface-ex-
pressed F protein. This approach was pursued because the
inhibition of all of the PDI-like isomerases using short inter-
fering RNA was not feasible. The results showed that the
overexpression of either of the isomerases led to enhanced
cell-cell fusion and favored a postfusion conformation of F
protein. These results are consistent with the conclusion that
free thiols have an important role in NDV membrane fusion
and suggest that other thiol isomerases with a CXXC motif are
involved in disulfide bond reduction in viral fusion glycopro-
teins and in virus entry.
MATERIALS AND METHODS
Cells, plasmids, and antibodies. COS-7 cells, obtained from the American
Type Culture Collection, were grown in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco) supplemented with nonessential amino acids, vitamins, pen-
icillin, streptomycin, and 10% fetal calf serum.
ERdj5 and PDI genes were purchased from the American Type Culture
Collection in pCMV-Sport6ccdB and pBluescript SK vectors, respectively. The
PDI gene was subcloned in the pCMV-Sport6ccdB vector using NotI and KpnI
restriction sites. NDV F and HN genes were inserted into pSVL and pCAGGS
expression vectors as previously described (17, 18).
Anti-Fu1a is a mouse monoclonal antibody specific for NDV F protein and
was obtained from M. Peeples. Anti-HR1 and anti-HR2 antibodies were raised
against peptides with sequences from the NDV F protein HR1 and HR2 do-
mains, respectively, and have been previously described (18). Anti-AS antibody
was raised against the peptide encoded between the AluI to SmaI sites in the HN
DNA (corresponding to amino acids 115 to 515) from the NDV HN protein and
has been previously described (18). Anti-NDV antibody was raised in rabbits
against UV-inactivated stocks of NDV, strain AV, by standard protocols as
previously described (17). Mouse monoclonal anti-PDI and anti-ERdj5 antibod-
ies were purchased from Abnova Corporation.
Transfection. The transfections of COS-7 cells were accomplished using
Lipofectamine or Lipofectin (Invitrogen) as recommended by the manufacturer.
For each transfection, a mixture of DNA (0.5 g/35-mm plate) and 7 l of
Lipofectamine or Lipofectin in OptiMEM medium (Gibco/Invitrogen) was
incubated at room temperature and added to cells previously washed with
OptiMEM. The cells were incubated for 5 h, and OptiMEM was replaced with
2 ml of supplemented DMEM and incubated for 40 to 48 h.
Surface biotinylation. COS-7 monolayers were grown in 35-mm plates and
transfected with cDNAs encoding the HN and F proteins and/or cDNAs encod-
ing PDI or ERdj5. When added, PDI inhibitors were added at 24 h posttrans-
fection. After 48 h, the monolayers were washed three times with PBS-CM
(phosphate-buffered saline with 0.1 mM CaCl2 and 1 mM MgCl2). PBS-CM
containing 0.5 mg/ml sulfo-NHS-SS [sulfosuccinimidyl 2-(biotinamido)-ethyl-1,3
dithiopropionate]-biotin (Pierce) was added, and cells were incubated for 40 min
at 4°C. Unbound biotin was absorbed with 2 ml DMEM containing fetal calf
serum (10%), and cells were washed three times with PBS and lysed with RSB
lysis buffer (0.01 M Tris-HCl [pH 7.4], 0.01 M NaCl, 1.5 mM MgCl2) containing
1% Triton X-100, 0.5% sodium deoxycholate, 2.5 mg of N-ethyl maleimide per
ml, and 0.2 mg of DNase per ml. Lysates were incubated for 1 h at room
temperature or overnight at 4°C with neutravidin-agarose (Pierce) containing
0.3% sodium dodecyl sulfate (SDS), and they were washed with PBS containing
0.5% Tween-20 and 5 mg/ml bovine serum albumin (BSA) and then with PBS
containing 0.5% Tween-20 and 1 mg/ml BSA. Precipitates were washed three
times with PBS containing 0.5% Tween-20 and 0.4% SDS, resuspended in gel
sample buffer (125 mM Tris-HCl, pH 6.8, 2% SDS, and 10% glycerol) with 0.7
M -mercaptoethanol, and resolved by polyacrylamide gel electrophoresis
(PAGE). Proteins were detected by Western blot analysis.
Biotinylation with MPB. MPB [3-(N-maleimidylpropionyl) biocytin] (Molec-
ular Probes) was used to biotinylate free thiols in cell surface proteins. At 48 h
after transfection, cells, grown in 35-mm plates, were washed with PBS-CM (PBS
with 0.1 mM CaCl2 and 1 mM MgCl2) and incubated with MPB (0.5 mM in PBS)
at 25°C for 30 min. Cells then were washed once with DMEM and twice with PBS
and lysed using RSB lysis buffer as described above. Proteins in extracts were
precipitated with neutravidin-agarose containing 0.3% SDS after having been
washed sequentially with PBS containing 0.5% Tween-20 and 5 mg/ml BSA and
PBS containing 0.5% Tween-20 and 1 mg/ml BSA. Precipitates were washed
three times with PBS containing 0.5% Tween-20 and 0.4% SDS and resolved by
SDS-PAGE and analyzed by Western blotting using anti-F (anti-HR2) antibody.
PAGE and Western blot analysis. Proteins in cell extracts or immunoprecipi-
tates, diluted in gel sample buffer (125 mM Tris-HCl, pH 6.8, 2% SDS, and 10%
glycerol) with 0.7 M ß-mercaptoethanol, were resolved on 10% polyacrylamide
gels. After electrophoresis, gels were equilibrated in transfer buffer (25 mM Tris,
pH 8.2, 192 mM glycine, 15% methanol) and transferred to Immobilon-P (Mil-
lipore Corp.) membranes. The membranes were blocked overnight at 4°C in PBS
containing 0.5% Tween 20 and 10% nonfat milk, washed with PBS-Tween 20,
and incubated for 1 h at room temperature with primary antibody diluted to
1:1,000 in PBS-Tween 20. Membranes were washed, incubated for 1 h at room
temperature with secondary antibody (goat anti-rabbit immunoglobulin G [IgG]
or anti-mouse IgG coupled to horseradish peroxidase) (Amersham Biosciences)
diluted to 1:40,000 in PBS-Tween 20, and then washed extensively in PBS-Tween
20. Bound antibody was detected using the ECL Western blotting detection
reagent system (Amersham Biosciences). The quantification of the signal was
accomplished using a Fluor-S imager (Bio-Rad).
Cell viability. COS-7 cell monolayers plated on a 12-well plate were trans-
fected with empty vector or with ERdj5 or PDI cDNA and with or without HN
and F cDNAs. At 48 h posttransfection, cells were incubated with 1 ml of MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Promega) (0.5
mg/ml in PBS) for 3 h at 37°C. After removing MTT, cells were treated with 1 ml
acidified isopropanol (0.04 M HCl in absolute isopropanol) to solubilize blue
formazan crystals, and the development of blue color was quantitated by mea-
suring the absorbance at 570 nm and subtracting the background measurement
at 650 nm (12, 21).
Syncytium formation. COS-7 cells, grown in 35-mm plates, were transfected
with HN and F cDNAs with or without ERdj5 or PDI cDNA (0.5 g/plate) using
Lipofectin as described above. The average number of nuclei per syncytium was
counted in 20 fusion areas for each plate at 24, 48, and 72 h. Values obtained
after transfection with empty vector were subtracted.
Content mixing. Content mixing was measured by using a modification of a
previously described protocol (19). Briefly, cells plated on 12-well plates were
transfected with pCAGGS-HN (0.04 g/well), pCAGGS-F (0.04 g/well)
cDNAs, and a plasmid carrying a tetracycline-responsive transcriptional activa-
tor, tTA (Clontech) (0.4 g/well). A separate population of cells was transfected
with a plasmid encoding the ß-galactosidase protein under the control of the
12040 JAIN ET AL. J. VIROL.
 at UNIV O
F M
ASS M
ED SCH on Novem






tetracycline-responsive transcriptional activator, pB1-G (Clontech) (0.4 g/well),
with or without ERdj5 or PDI cDNA (0.2 g/well). After 40 h, the cells trans-
fected with pB1-G were removed from the plate with trypsin and placed on top
of the HN protein- and F protein-expressing cells. Cells were further incubated
for 6 h, washed twice with PBS, and lysed (in Promega cell lysis buffer), and
extracts were assayed for ß-galactosidase activity as described in the protocols
from Promega. Activity due to the background fusion of COS-7 cells was mea-
sured after mixing cells cotransfected with pTA and vector alone with cells
transfected with pB1-G, and values obtained were subtracted from values ob-
tained with cells expressing HN and F proteins.
Immunofluorescence. COS-7 cells were grown in 35-mm plates containing
glass coverslips and were transfected with cDNAs encoding HN and F proteins
with or without ERdj5 or PDI cDNA. After 36 h, one set of cells was treated with
neuraminidase (0.25 U/ml). After 48 h, one set of cells was treated with MPB for
30 min as described above and further incubated for 3 h at 37°C. The cells were
washed twice with ice-cold IF buffer (PBS containing 1% bovine serum albumin,
0.02% sodium azide, and 0.01% CaCl2) and incubated for 1 h at 4°C in IF buffer.
Cells were incubated at 4°C for 1 h with IF buffer containing antibody (diluted
1:200). The cells were washed three times with ice-cold IF buffer and incubated
for 1 h on ice with IF buffer containing Alexa 488-labeled anti-rabbit IgG or
Alexa 570-labeled anti-mouse IgG (diluted 1:200). The cells were washed with
ice-cold IF buffer, fixed with 2% paraformaldehyde, and mounted for microscopy
(Nikon Diaphot 300 fluorescence microscope).
The quantification of surface immunofluorescence was accomplished by de-
termining the mean fluorescence intensities for cells using Adobe Photoshop as
described previously (31). Individual cells were outlined manually using the lasso
tool on immunofluorescence pictures opened in Photoshop. The mean fluores-
cence values of selected areas were determined with the histogram submenu.
Background fluorescence values were obtained from empty vector-transfected
cells and were subtracted from the values obtained from cells expressing HN and
F proteins.
RESULTS
Overexpression of ERdj5 and PDI in COS-7 cells and effects
on cell viability and NDV glycoprotein expression. To explore
the effects of the overexpression of PDI-like isomerases on
membrane fusion, we first examined the expression of two
different members of the PDI isomerase family, PDI and
ERdj5, after the transfection of cells with cDNAs encoding
these isomerases. As shown in Fig. 1A, COS-7 cells transfected
with ERdj5 or PDI cDNA expressed the respective proteins at
1.5- and 1.8-fold the levels of untransfected cells.
To determine if the increased expression of these isomerases
affected cell viability, MTT, a compound that is metabolized to
form blue formazan crystals in live cells (21), was used. COS-7
cells transfected with cDNA encoding ERdj5 or PDI and with
or without HN and F protein cDNA were incubated with MTT,
and the development of blue color in these cells was compared
to that of untransfected cells or cells transfected with HN and
FIG. 1. Overexpression of ERdj5 and PDI and its effect on HN and F protein expression and cell viability. (A) Proteins in extracts of COS-7
cells, transfected with empty vector or cDNA encoding ERdj5 (top) or PDI (bottom), were resolved by SDS-PAGE and analyzed by Western
blotting. The blots, with actin as a loading control, are shown below each panel. Numbers at bottom of each panel represent the expression of the
respective proteins in transfected cells as a percentage of expression in untransfected cells. The quantification was performed in films with protein
bands in the linear range. (B) Cells, untransfected (UT) or at 48 h after transfection with ERdj5 or PDI cDNA and with or without F and HN
protein cDNA, were incubated with MTT for 3 h at 37°C. The blue metabolic product of MTT, measured as the optical density at 570 nm, is
represented as a percentage of the value obtained for untransfected cells. The values represented are averages from three different experiments,
and error bars represent the ranges. (C) Cells were transfected with empty vector (lanes 2 and 6) or were cotransfected with HN and F protein
cDNAs (lanes 3 and 7) or HN and F protein with ERdj5 cDNA (lanes 4 and 8) or with PDI cDNA (lanes 5 and 9). Surface HN protein (top) or
F protein (bottom), biotinylated using sulfo-NHS-SS-biotin, was precipitated with neutravidin-agarose (lanes 6 to 9), and total F or HN protein
in the extracts (lanes 2 to 5) was resolved by SDS-PAGE and analyzed by Western blotting using anti-F protein antibody (anti-HR2) or anti-HN
protein antibody (anti-AS). The amount of the total extract loaded represents one-third of the amount of extract used to precipitate biotinylated
surface proteins. Lane 1 shows the infected cell extract that was used as a marker. (D) Surface expression of PDI. Cells were transfected with
increasing amounts of cDNAs encoding PDI and, 48 h post transfection, cells were incubated with sulfo-NHS-SS-biotin. Biotinylated cell surface
proteins in aliquots of the resulting cell extracts were precipitated with neutravidin (lanes 2, 4, 6, 8, and 10). Lanes 1, 3, 5, 7, and 9 show protein
precipitated with equivalent amounts of agarose coupled to protein G as a negative control. PDI in the precipitates was detected with anti-PDI
antibody in a Western blot. Top panel, lanes 1 and 2, no PDI cDNA; lanes 3 and 4, 0.25 g PDI cDNA; lanes 5 and 6, 0.5 g PDI cDNA; lanes
7 and 8, 0.75 g PDI cDNA; and lanes 9 and 10, 1 g PDI cDNA. Bottom panel, the detection of actin in each extract.
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F cDNAs only. As shown in Fig. 1B, the overexpression of
ERdj5 or PDI did not decrease cell viability. In addition, as
MTT is a measure of metabolic activity (21), the results suggest
that the overexpression of isomerases did not increase cell
division.
To determine the effect of the overexpression of these
isomerases on the surface expression and the total expression
of HN or F protein, surfaces of COS-7 cells expressing HN and
F proteins with or without ERdj5 or PDI were biotinylated
using sulfo-NHS-SS-biotin. Lysates of these cells were precip-
itated with neutravidin-agarose to detect the biotinylated sur-
face proteins. The total HN and F proteins in the resulting cell
lysates were determined by Western blot analysis. The results
in Fig. 1C show that neither the total expression of HN or F
protein (lanes 3 to 5) nor the surface expression of HN or F
protein (lanes 7 to 9) was affected by the overexpression of
ERdj5 or PDI.
To verify that, as previously reported, PDI can be detected
at cell surfaces and that increased expression resulted in the
increased surface expression of this host protein, surfaces of
cells transfected with increasing amounts of cDNAs encoding
PDI were biotinylated with sulfo-NHS-SS-biotin. Proteins in
lysates of these cells were precipitated with neutravidin-aga-
rose to precipitate, specifically, cell surface molecules. Figure
1D, top, shows that PDI was biotinylated and that increased
expression results in increased amounts of the protein on cell
surfaces. The surface expression of ERdj5 was not detected in
a similar assay. The amount of total PDI detected on cell
surfaces was approximately 0.5 to 1.5% of total cell-associated
PDI. This level of ERdj5 was below the limits of detection of
this protein using available antibodies, which may account for
the failure to detect the protein at cell surfaces.
ERdj5 or PDI overexpression in cells expressing HN and F
proteins enhances cell-cell fusion. To determine the effect of
the overexpression of these thiol isomerases on cell-cell fusion,
we compared the sizes of syncytia in cells cotransfected with
cDNA encoding HN, F, and ERdj5 or PDI protein to those in
cells transfected only with cDNAs encoding HN and F pro-
teins. Figure 2A shows representative cell monolayers visual-
ized by immunofluorescence using anti-NDV antibody. Syncy-
tia in monolayers overexpressing ERdj5 or PDI isomerase
were noticeably larger than syncytia in monolayers expressing
HN and F proteins only. This result was quantified by deter-
mining the average number of nuclei per syncytium in cells
FIG. 2. Effect of ERdj5 and PDI overexpression on cell-cell fusion. (A) Syncytia were visualized by the immunofluorescence of cells using
anti-NDV antibody. Cells transfected with empty vector or cotransfected with HN and F protein cDNAs with or without ERdj5 or PDI cDNA were
processed for immunofluorescence at 48 h posttransfection. (B) Average sizes of syncytia after transfection with HN and F protein cDNAs
(HNF), HN, F, and ERdj5 cDNAs (HNFE), or HN, F, and PDI cDNAs (HNFP) were determined by counting the number of nuclei per
syncytium in 20 different fusion areas at 24, 48, and 72 h posttransfection. The results shown are the averages of three independent experiments,
with the error bars indicating standard deviations. (C) Effects of the overexpression of ERdj5 and PDI on content mixing were assayed using a
ß-galactosidase reporter assay. Effector cells cotransfected with HN and F protein cDNAs as well as with pTA were mixed with target cells
(transfected with pB1-G with or without ERdj5 or PDI). Content mixing between effector and target cells was quantified by measuring
ß-galactosidase in cell extracts and is shown as a percentage of the activity detected in cells transfected with HN and F cDNAs (HNF). The results
shown are the averages of three independent experiments, and the error bars indicate the range.
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expressing HN and F proteins with or without isomerases. As
shown in Fig. 2B, the average number of nuclei per syncytium,
determined at different time points after transfection, was two-
fold higher in cells overexpressing ERdj5 or PDI than in cells
expressing HN and F proteins only.
Cell-cell fusion also was measured by a cytoplasmic content
mixing assay as described in Materials and Methods. Results in
Fig. 2C and 3A show that the overexpression of ERdj5 or PDI
increased content mixing by three- to fourfold. This increase
was observed when only target cells were transfected with
cDNA encoding PDI or ERdj5 (Fig. 2C). Identical results were
obtained when only effector cells were transfected with cDNA
encoding either isomerase (not shown). When both target and
effector cells were transfected with cDNAs encoding the
isomerases, the enhancement of fusion was further stimulated
by approximately 20% (not shown). That enhanced fusion was
observed when target cells overexpress only PDI or ERdj5 is
consistent with the conclusion that it is cell surface thiol
isomerases that are involved in the enhanced fusion and not
intracellular effects of the isomerases on the F or HN protein.
To determine if this increase in cell-cell fusion in cells over-
expressing ERdj5 or PDI protein was due directly to the in-
creased production of free thiols, we characterized the effect of
an inhibitor of free thiols on cytoplasmic content mixing in
cells overexpressing ERdj5 or PDI proteins. DTNB, a nonspe-
cific inhibitor of free thiols (6), efficiently inhibited the content
mixing in cells overexpressing ERdj5 or PDI protein as well as
in cells expressing NDV glycoproteins alone (Fig. 3A). This
result showed that the increased fusion also was dependent on
thiol isomerase activity.
To determine if the increased fusion was due directly to the
overexpression of the isomerases, we determined the effect of
antibodies specific to the PDI protein (Fig. 3B) or ERdj5
protein (Fig. 3C) on the enhanced cell-cell fusion. In the pres-
ence of antibody to PDI or ERdj5, content mixing in cells
overexpressing PDI or ERdj5, respectively, was significantly
reduced to levels below those seen in cells not overexpressing
the isomerases. This result suggests that increased fusion is due
directly to the increased levels of surface PDI or ERdj5. The
results also are consistent with the proposal that other thiol
isomerases also can function in fusion, since neither antibody
could completely inhibit fusion, as shown here and previously
(12).
Effect of overexpression of ERdj5 and PDI on detection of
free thiols in F protein expressed with or without HN protein.
To determine directly if the overexpression of ERdj5 or PDI
protein leads to an alteration in the detection of free thiols in
F protein, surfaces of cells expressing F protein with either of
the isomerases were labeled with a thiol-reactive biotin, MPB.
MPB links to the free thiols in proteins on cell surfaces and
thus biotinylates those proteins (11). We have previously re-
ported that the surface-expressed F protein, but not the HN
protein, is labeled with this reagent (12). The cell surface
proteins labeled with MPB were precipitated with neutravidin-
agarose, and the amount of protein precipitated was normal-
ized to the amount of total F protein in the extracts. Figure 4A
shows that the detection of free thiols in both F0 and F1
proteins, expressed in the absence of HN protein, was in-
creased in cells cotransfected with cDNA encoding PDI or
ERdj5. The labeling of F1 was increased by slightly more than
twofold in cells overexpressing the isomerases (Fig. 4A).
We also determined the effects of the overexpression of the
isomerases on the detection of free thiols in F protein coex-
pressed with HN protein. We previously reported that levels of
MPB binding to F protein were only slightly affected by coex-
pression with HN protein (12). Interestingly, the overexpres-
sion of ERdj5 or PDI protein resulted in the significantly
decreased detection of free thiols in F protein in the presence
of HN protein (Fig. 4B). This result is consistent with the
proposal that, due to the increased fusion in cells overexpress-
ing the isomerases, more of the steady-state cell surface F
protein is in a postfusion conformation, and that this confor-
mation is not a substrate for thiol isomerases.
FIG. 3. Effect of inhibitors of PDI isomerases on cell-cell fusion in
cells overexpressing ERdj5 or PDI. The effects of DTNB (A), anti-PDI
antibody (B), or anti-ERdj5 antibody(C) were assayed using a ß-ga-
lactosidase reporter assay, as described in Materials and Methods.
Effector cells cotransfected with HN and F protein cDNAs as well as
pTA were mixed with target cells (transfected with pB1-G with or
without ERdj5 or PDI) in the presence of DTNB (A), anti-PDI anti-
body (B), or anti-ERdj5 antibody (C). ß-Galactosidase activity in cell
extracts represents content mixing and is shown as a percentage of the
activity detected in cells transfected only with HN and F cDNAs
(HNF). The results represent the average of three independent ex-
periments with the error bars representing the range.
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No free thiols were detected in the HN protein (12), even
when PDI or ERdj5 was over expressed (not shown).
Overexpression of ERdj5 or PDI in cells expressing HN and
F proteins favors the postfusion conformation of F protein.
Previously we showed that the binding of two different confor-
mation-sensitive anti-F protein antibodies, anti-Fu1a and anti-
HR1 antibodies, to cell surface F protein expressed with HN
protein was altered in the presence of the inhibitors of free
thiols (12). Anti-HR1 antibody was raised against an HR1
peptide and, thus, binds the HR1 domain. Anti-Fu1a likely
binds the fusion peptide, since a point mutation in the fusion
peptide inhibits the binding of the antibody to the mature
protein (29). Anti-Fu1a binding was increased and the binding
of anti-HR1 was decreased by the inhibition of isomerases and
fusion (12). This result suggested that these antibodies differ-
entially bind to pre- and postfusion conformations of F pro-
tein. We further analyzed the binding of these antibodies to
cell surface F protein expressed with HN protein in the pres-
ence or absence of exogenous neuraminidase (Fig. 5) in order
to define further the form of F protein recognized by these
antibodies. In cells incubated overnight with exogenous neur-
aminidase, the majority of cell surface F protein is likely to be
in a prefusion conformation, since the absence of cell receptors
for HN protein will inhibit HN protein binding and F protein
activation. In cells grown in the presence of exogenous neur-
aminidase, the binding of anti-Fu1a antibody (Fig. 5A and B)
FIG. 4. Effect of ERdj5 and PDI overexpression on the production
of free thiols in F protein when expressed without (A) or with (B) HN
protein. Cells transfected with empty vector, F protein cDNA, or HN
and F protein cDNAs with or without ERdj5 or PDI cDNA were
labeled with MPB as described in Materials and Methods. Proteins in
resulting cell extracts were precipitated with neutravidin-agarose
(lanes 1 to 4) and resolved by SDS-PAGE. Total F protein in cell
extracts (lanes 5 to 8) was resolved as a control for the expression of
the proteins. The quantification of F1 labeled by MPB is shown at the
bottom of each panel and was performed in films with protein bands in
the linear range.
FIG. 5. Binding of conformation-sensitive antibodies to F protein on cell surfaces in the presence of MPB or neuraminidase (NAase). (A, C,
and E) Cells transfected with pSVL vector (top panels) or with pSVL-HN and pSVL-F (bottom panels) were processed for surface immunoflu-
orescence using anti-Fu1a antibody, anti-HR1 antibody, and anti-NDV antibody, respectively (indicated on the left). Column 1 shows cells without
any treatment, and columns 2 and 3 show cells treated with MPB and neuraminidase, respectively, as described in Materials and Methods. (B, D,
and F) Quantification of the fluorescence intensities of the cells shown in panels A, C, and E, respectively. The results shown are averages of the
mean fluorescence intensity of 10 different cells and are normalized for background fluorescence by subtracting the mean fluorescence of cells
transfected with empty vector. Error bars represent the range of fluorescence intensity of 10 different cells within one experiment, and the
experiment shown is representative of three similar experiments.
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was increased five- to sixfold compared to that of untreated
cells (first lane), and the binding of anti-HR1 antibody (Fig. 5C
and D) was inhibited. The binding of anti-NDV antibody, a
control antibody (Fig. 5E and F), was not affected. These
results suggest that anti-Fu1a antibody recognizes primarily F
protein in prefusion conformation, and anti-HR1 antibody
binds better to F protein in an intermediate conformation or,
perhaps, a postfusion state. Similar results were seen when
fusion was inhibited by MBP linkage (12) (Fig. 5, middle lane).
These results are consistent with our previous results that the
binding of anti-Fu1a antibody is increased, and the binding of
anti-HR1 antibody is inhibited, when cells are treated with
inhibitors of free thiols, DTNB and bacitracin, conditions that
also inhibit fusion (12). Taken together, these results argue
that anti-Fu1a preferentially detects prefusion F protein, while
anti-HR1 detects F protein after its activation.
We next determined the effects of the overexpression of
ERdj5 and PDI proteins on the binding of these conformation-
sensitive anti-F protein antibodies (Fig. 6A to D). As shown in
Fig. 6A and B, the binding of anti-Fu1a antibody was de-
creased by the overexpression of isomerases, while the binding
of anti-HR1 antibody (Fig. 6C and D) was increased by the
overexpression of isomerases. As shown above, the overexpres-
sion of these isomerases enhanced fusion and, thus, increased
the amount of the postfusion form of F protein. The binding of
anti-NDV antibody (Fig. 6E and F) was not affected. These
results suggested that the majority of F protein in these cells is
in a postfusion conformation when fusion is stimulated by the
increased expression of isomerases.
DISCUSSION
In this study, we evaluated the effect of the overexpression of
the thiol isomerases PDI and ERdj5 on the activity and con-
formation of the NDV F protein. The overexpression of either
isomerase resulted in significantly increased cell-cell mem-
brane fusion mediated by NDV glycoproteins. The overexpres-
sion of either isomerase also resulted in the increased detec-
tion of free thiols in F protein expressed in the absence of HN
protein and a decreased detection of free thiols in F protein
expressed with HN protein. The overexpression of these
isomerases also altered the binding of two different conforma-
tion-sensitive antibodies in a manner consistent with an en-
hanced population of surface-expressed F protein in a postfu-
sion conformation in the presence of HN protein.
While increased fusion upon the overexpression of the thiol
isomerases could be an indirect effect of this overexpression,
results presented here are most consistent with the proposal
that the increased fusion activity of the F protein is a direct
result of increased cell surface thiol isomerase activity. First,
the overexpression of PDI or ERdj5 increased the levels of
each of these isomerases in total cell extracts. Furthermore, the
FIG. 6. Effect of ERdj5 and PDI overexpression on the binding of conformation-sensitive antibodies to F protein on cell surfaces. (A, C, and
E) Cells transfected with pSVL vector (top panels) or with pSVL-HN and pSVL-F (bottom panels) were processed for surface immunofluores-
cence using anti-Fu1a antibody, anti-HR1 antibody, and anti-NDV antibody, respectively (indicated on left). Column 2 shows cells transfected with
ERdj5 cDNA along with pSVL or pSVL-HN and pSVL-F, and column 3 shows cells transfected with PDI cDNA along with pSVL or pSVL-HN
and pSVL-F. (B, D, and F) Quantification of mean fluorescence intensities of the cells shown in panels A, C, and E, respectively. The results shown
are averages of the mean fluorescence intensity of 10 different cells and are normalized for background fluorescence by subtracting the mean
fluorescence of cells transfected with empty vector. Error bars represent the range of fluorescence intensity of 10 different cells within one
experiment, and the experiment shown is representative of three similar experiments.
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levels of surface PDI were significantly increased. Second, the
overexpression of either isomerase increased the detection of
free cysteines in the population of cell surface F protein nearly
twofold over the levels we previously detected in the F protein
(12), suggesting a direct effect on F protein. Third, we showed
that increased fusion was observed only when target cells were
overexpressing either thiol isomerase. This result argues
against an indirect effect of the thiol isomerases on the folding
of intracellular F protein. The result also is consistent with the
increased levels of PDI or ERdj5 on target cell surfaces. While
the increased expression of ERdj5 in target cells could indi-
rectly affect the expression of another protein on target cell
surfaces, the finding that antibody specific to ERdj5 inhibited
the increased fusion is more consistent with the direct effects of
ERdj5 on cell surfaces. Fourth, we have shown previously that
the inhibition of thiol isomerases with membrane-imperme-
able, specific inhibitors such as DTNB or bacitracin blocked
the appearance of free cysteines in the F protein and blocked
fusion (12). Here, we showed that DTNB also blocked fusion
in cells overexpressing PDI or ERdj5. This observation is con-
sistent with the conclusion that the increased expression of
thiol isomerase activity at cell surfaces directly affected fusion.
Fifth, the increased fusion, resulting from the overexpression
of either isomerase, was significantly decreased by antibodies
specific for the isomerase overexpressed. That both antibodies
significantly decreased the enhanced fusion activity suggested
that the enhanced fusion is due directly to the increased ex-
pression of the specific thiol isomerases and that both isomer-
ases are at cell surfaces. That neither antibody completely
inhibited fusion likely is due to the redundancy in cells of
proteins with thiol isomerase activity. In the presence of spe-
cific thiol isomerase antibodies, other isomerases are still func-
tional.
An alternative possibility to account for the results pre-
sented here is that the increased expression of thiol isomerases
increased the efficiency of the proper folding of the F protein,
increased concentrations of fusion-competent F protein, and,
therefore, increased fusion. However, our results showed that
there are not increased levels of F protein on cell surfaces in
the presence of excess thiol isomerases. Furthermore, our
results showed that fusion is increased significantly when isom-
erases are expressed on target cells only. This increase was
identical to increases observed when the isomerases were
transfected into effector cells only. This result argues that the
increased thiol isomerase activity affects F protein at cell sur-
faces. It is unlikely that an improperly folded F protein is
delivered to cell surfaces for repair by cell surface isomerases,
since improperly folded proteins are not likely transported to
cell surfaces but are subject to ER quality control mechanisms
that degrade abnormally folded proteins (22).
The combined results presented here and previously (12)
suggest that, prior to fusion activation, cell surface F protein
exists in several forms that are in equilibrium, and the concen-
tration of each form reflects the concentration of surface
isomerases (illustrated in the model shown in Fig. 7). These
results, as well as previous results that showed that the binding
of thiol-reactive MPB blocked fusion (12), suggest that it is the
form containing free thiols that proceeds through the confor-
mational changes, which results in cell-cell fusion (Fig. 7).
When HN protein was coexpressed with F protein and the
thiol isomerases, we found that the MPB labeling of F protein
was reduced to about 50% of the level of MPB labeling of F
protein when expressed with HN protein in the absence of the
enhanced expression of an isomerase. One possibility for the
decreased MPB labeling of F protein seen in this case is that,
in the presence of HN and the isomerases, cell-cell fusion is
enhanced and more steady-state F protein is in the postfusion
conformation. Postfusion F protein is thought to be a very
stable structure and, therefore, may not be a substrate for thiol
isomerases and may not be labeled by MPB.
We utilized conformation-sensitive antibodies to explore
this hypothesis. We found that the binding of anti-Fu1a anti-
body was significantly enhanced under conditions that inhib-
ited fusion, while anti-HR1 antibody bound preferentially to F
protein when fusion was not inhibited. Anti-Fu1a antibody is
thought to bind near the fusion peptide, since the mutation of
amino acid 123, located seven amino acids from the amino-
terminal end of F1, eliminated the binding of this antibody to
F protein (29) without having an effect on the intracellular
processing of the protein. Thus, this mutation does not likely
have global effects on the conformation of the protein, which
could account for the failure to bind anti-Fu1a. Anti-HR1
antibody, raised against an HR1 peptide, binds the HR1 do-
main in F protein.
According to current models proposed for conformational
changes in F protein during membrane fusion (26, 37), the first
conformational change in F protein is the disassociation of
HR2 domains in the trimer. Subsequently, the HR1 domain
unfolds and then refolds into an extended trimeric helix, re-
sulting in the insertion of the fusion peptide, which is at the tip
of the helix, into target cell membranes. F protein in this state
is referred to as prehairpin intermediate. After the insertion of
fusion peptide into the target membrane, the next proposed
major conformational change involves the refolding of F pro-
tein into a stable trimer of hairpins formed by the complexing
of the HR1 and HR2 domains into a six-helix bundle (6HB).
The refolding of F protein into this postfusion form leads to
the close approach and fusion of the target and effector mem-
branes.
FIG. 7. Model for the role of free thiols in NDV F protein. (A) F
protein is present in a prefusion, metastable conformation with intact
disulfide bonds. Disulfide bonds are cleaved by PDI-like isomerase,
resulting in free thiols in F protein (B) before the major conforma-
tional changes in F protein required for fusion (C). MPB binds to the
free thiols in F protein, and the binding of MPB prevents further
conformational changes and the fusion of membranes. Anti-Fu1a an-
tibody binds to F protein in the prefusion state, while anti-HR1 anti-
body binds preferentially to the activated or postfusion form of F
protein. The enhanced expression of PDI or ERdj5 favors the confor-
mation shown in panel C at steady state. S-S, disulfide bond; SH, free
or reduced cysteine.
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Since anti-Fu1a binds preferentially to F protein when fu-
sion activation is inhibited, it is likely that the anti-Fu1a anti-
body binds preferentially to a prefusion conformation of F
protein before any major conformational change. In the pro-
posed prefusion conformation of the parainfluenza virus 5 F
protein (37), the amino acid comparable to the NDV F protein
amino acid 123 in the fusion peptide is exposed on the surface
of the trimer. This structure was formed with an uncleaved F
protein in the absence of the HN protein. However, if this
structure represents the conformation of the prefusion,
cleaved NDV F protein in the presence of HN protein, the
region around amino acid 123 should be accessible to anti-
Fu1a in the prefusion F protein. Upon insertion into a mem-
brane, the fusion sequence, buried in a target membrane,
would be masked from antibody binding. In contrast, it is likely
that anti-HR1 antibody will bind preferentially to the HR1
trimer in the prehairpin conformation or subsequent interme-
diate forms of the F protein. The results of antibody binding in
cells treated with neuraminidase, which prevents receptor
binding and, consequently, fusion, were consistent with the
predicted binding for these antibodies. Our previous findings
that inhibitors of thiol isomerases blocked fusion and increased
the binding of anti-Fu1a and decreased anti-HR1 binding (12)
also are consistent with this conclusion. We have shown pre-
viously that MPB binding to free thiols also blocks fusion (12).
Here, we showed that, after MPB binding, the anti-Fu1a anti-
body binding increases and anti-HR1 antibody binding de-
creases. These combined results suggest that the binding of
MPB leads to the presence of more F protein in the prefusion
state. In addition, MPB also may bind to and inactivate cell
surface thiol isomerases, and this inactivation may result in a
decrease in disulfide bond reduction in F protein, the inhibi-
tion of fusion, and the presence of more F protein in the
prefusion form. In either case, this result further confirmed
that when free thiols are blocked, F protein is in the prefusion
conformation.
In contrast, when isomerases were overexpressed, fusion was
significantly enhanced, and the binding of anti-Fu1a antibody
decreased and that of the anti-HR1 antibody increased. These
results suggested that the overexpression of the isomerases
significantly changed the conformation of the F protein, and it
is likely that the majority of F protein, under these conditions,
is in a postfusion conformation.
The overall implication of these results is that, in the ab-
sence of free thiols, F protein is in a prefusion conformation, as
illustrated in Fig. 7. The overexpression of isomerases in-
creases the concentration of an early conformational interme-
diate with free thiols. In the absence of HN protein expression,
no further changes take place. However, when disulfide bonds
are reduced, F protein, in the presence of HN protein, may
move into conformations that reflect the postfusion form or
intermediate forms. The reduction of disulfide bonds in F
protein may facilitate the conformational changes in F protein
required for membrane fusion (Fig. 7).
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